Background and purpose: Salvinorin A, the active component of the hallucinogenic herb Salvia divinorum, inhibits intestinal motility through activation of k-opioid receptors (KORs). However, this compound may have target(s) other than the KORs in the inflamed gut. Because intestinal inflammation upregulates cannabinoid receptors and endogenous cannabinoids, in the present study we investigated the possible involvement of the endogenous cannabinoid system in salvinorin A-induced delay in motility in the inflamed gut. Experimental approach: Motility in vivo was measured by evaluating the distribution of a fluorescent marker along the small intestine; intestinal inflammation was induced by the irritant croton oil; direct or indirect activity at cannabinoid receptors was evaluated by means of binding, enzymic and cellular uptake assays. Key results: Salvinorin A as well as the KOR agonist U-50488 reduced motility in croton oil treated mice. The inhibitory effect of both salvinorin A and U-50488 was counteracted by the KOR antagonist nor-binaltorphimine and by the cannabinoid CB 1 receptor antagonist rimonabant. Rimonabant, however, did not counteract the inhibitory effect of salvinorin A on motility in control mice. Binding experiments showed very weak affinity of salvinorin A for cannabinoid CB 1 and CB 2 and no inhibitory effect on 2-arachidonoylglycerol and anandamide hydrolysis and cellular uptake. Conclusions and implications: The inhibitory effect of salvinorin A on motility reveals a functional interaction between cannabinoid CB 1 receptors and KORs in the inflamed-but not in the normal-gut in vivo.

The negative regulation of p53, a major human tumor suppressor, by Mdm2 and Mdmx is crucial for the survival of a cell, whereas its aberrant function is a common feature of cancer.  Both Mdm proteins act through the spatial occlusion of the p53 transactivation (TA) domain and by the ubiquitination of p53, resulting in its degradation.  Two p53 homologues, p63 and p73, have been described in humans.  Unlike p53, these proteins regulate developmental processes rather than genome stability.  Both p63 and p73 contain TA domains homologous to that of p53, but relatively little is known about their regulation by Mdm2 or Mdmx.  Here, we present a detailed characterization of the interaction of Mdm2 and Mdmx with the TA domains of p63 and p73. Earlier reports of Mdm2 and Mdmx interactions with p73 are substantiated by the detailed quantitative characterization reported in this study. Most importantly, earlier contradictions concerning the presumed interaction of the Mdm proteins with p63 are convincingly resolved and for the first time, the affinities of these interactions are determined.  Finally, the contribution of these findings to our understanding of the physiological role of these interactions is discussed.

The radical cations generated from three NADH model compounds were investigated with particular emphasis on the possible formation of tautomeric enol radical cations. To a small extent, hydrogen transfer occurs upon ionization of all three compounds in argon matrixes. In the bicyclic seven-membered ring derivative enolization continues in a thermal reaction at 12 K (with highly dispersive kinetics), or upon visible irradiation. These processes are not observed in methylcyclohexane glasses at 77 K, which indicates that a cage effect is preventing the attainment of a reactive conformation in this medium. The assignment of electronic spectra of the primary (keto) cations and of their tautomeric (enol) forms is supported by CASSCF/CASPT2 and TD-B3LYP calculations.

The neoclerodane diterpenoid salvinorin A is a major secondary metabolite isolated from the psychoactive plant Salvia divinorum. Salvinorin A has been shown to have high affinity and selectivity for the κ-opioid receptor (KOR). To study the ligand–receptor interactions that occur between salvinorin A and the KOR, a new series of salvinorin A derivatives bearing potentially reactive Michael acceptor functional groups at C-2 was synthesized and used to probe the salvinorin A binding site. The κ-, δ-, and μ-opioid receptor (KOR, DOR and MOR, respectively) binding affinities and KOR efficacies were measured for the new compounds. Although none showed wash-resistant irreversible binding, most of them showed high affinity for the KOR, and some exhibited dual affinity to KOR and MOR. Molecular modeling techniques based on the recently-determined crystal structure of the KOR combined with results from mutagenesis studies, competitive binding, functional assays and structure–activity relationships, and previous salvinorin A–KOR interaction models were used to identify putative interaction modes of the new compounds with the KOR and MOR.

The O‐insertion reaction of a 7‐phos‐ phanorbornene (3) unsubstituted on the double‐ bond gave the corresponding 2,3‐oxaphosphabicyclo‐ [2.2.2]octene oxide (4a) in a regioselective manner that was useful in the fragmentation‐related phosphonylation of alcohols. Both the UV‐light mediated and the thermoinduced phosponylation accomplished on the bridged P‐heterocycle (4a) were found to be sensitive toward steric factors, suggesting that beside the well‐known elimination–addition reaction path taking place via metaphosphonate (11), a competitive novel addition‐‐elimination route involving an intermediate with a pentacoordinated P‐atom (12) is also present. This was confirmed by the kinetic consideration of our experimental data. © 2006 Wiley Periodicals, Inc. Heteroatom Chem 17:369–375, 2006; Published online in Wiley InterScience (http://www.interscience.wiley.com). DOI 10.1002/hc.20213

Depending on the molar ratio of the reactants and on the order of mixing, the reactions of a series of primary amines with 1-chloro-2,5-dihydro-1H-phosphole 1-oxides prepared in situ from the corresponding hydroxy-dihydrophosphole oxides afforded 1-amino-2,5-dihydro-1H-phosphole 1-oxides, or their N-phosphinoyl derivatives, bis(2,5-dihydro-1H-phosphol-1-yl)amine P,P′-dioxides. The latter family of P-heterocycles could also be synthesized by the reaction of 1-amino-2,5-dihydro-1H-phosphole oxides with chloro-dihydrophosphole oxides.

No abstract

No abstract